Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 17, 2024 Category: Gastroenterology Source Type: research
Safety and efficacy of endoscopic retrograde cholangiopancreatography in pediatric pancreatic and biliary disorders
ConclusionERCP can be safely and effectively performed in children using standard duodenoscope. Chronic pancreatitis, choledocholithiasis and pancreatic divisum are common pediatric ERCP indications.Graphical Abstract (Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 17, 2024 Category: Gastroenterology Source Type: research
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 17, 2024 Category: Gastroenterology Source Type: research
Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child –Pugh, model for end-stage liver diseases and indocyanine green dye test
ConclusionNTLV showed a significant negative correlation with ICG-r15% in cirrhotic patients with HCC, but not in cirrhotic patients without HCC. Therefore, CT volumetry can be a valuable tool to predict the functional hepatic volume in patients of cirrhosis with HCC subjected for hepatectomy, where a facility of ICG-r15% is not available. However, further studies are needed to validate our findings in cirrhotic only patients.Graphical Abstract (Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 13, 2024 Category: Gastroenterology Source Type: research
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice
AbstractRising number of inflammatory bowel disease (IBD) cases in developing countries necessitate clear guidance for clinicians for the appropriate use of advanced therapies. An expert consensus document was generated to guide the usage of tofacitinib, a Janus kinase inhibitor, in ulcerative colitis. Tofacitinib is a useful agent for the induction and maintenance of remission in ulcerative colitis. It can be used in the setting of biological failure or even steroid-dependent and thiopurine refractory disease. Typically, the induction dose is 10 mg BD orally. Usually, clinical response is evident within eight weeks of...
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Utility of commercially available triple drug regimen kits and addition of Lactobacillus reuteri in Helicobacter pylori eradication
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Clinical profile of patients with ulcerative colitis- A hospital based study from Madhya Pradesh
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Post-transarterial chemoembolization lipiodol migration with obstructive biliopathy
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Colonoscopic retrieval of transmigrated intrauterine contraceptive device from the rectum
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Tofacitinib use in ulcerative colitis: An expert consensus for day-to-day clinical practice
AbstractRising number of inflammatory bowel disease (IBD) cases in developing countries necessitate clear guidance for clinicians for the appropriate use of advanced therapies. An expert consensus document was generated to guide the usage of tofacitinib, a Janus kinase inhibitor, in ulcerative colitis. Tofacitinib is a useful agent for the induction and maintenance of remission in ulcerative colitis. It can be used in the setting of biological failure or even steroid-dependent and thiopurine refractory disease. Typically, the induction dose is 10 mg BD orally. Usually, clinical response is evident within eight weeks of...
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Utility of commercially available triple drug regimen kits and addition of Lactobacillus reuteri in Helicobacter pylori eradication
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Clinical profile of patients with ulcerative colitis- A hospital based study from Madhya Pradesh
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Post-transarterial chemoembolization lipiodol migration with obstructive biliopathy
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
Colonoscopic retrieval of transmigrated intrauterine contraceptive device from the rectum
(Source: Indian Journal of Gastroenterology)
Source: Indian Journal of Gastroenterology - February 12, 2024 Category: Gastroenterology Source Type: research
